These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30168966)

  • 1. [Multiple Myeloma: from Diagnosis to the Up-to-date Treatment. Topics: IV. Multiple Myeloma with Renal Impairment and Monoclonal Gammopathy of Renal Significance].
    Mizuno S
    Nihon Naika Gakkai Zasshi; 2016 Jul; 105(7):1224-30. PubMed ID: 30168966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal impairment in multiple myeloma and related disorders].
    Wakui H
    Rinsho Ketsueki; 2013 Oct; 54(10):1876-87. PubMed ID: 24064839
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary proteins and renal dysfunction in patients with multiple myeloma.
    Corso A; Zappasodi P; Lazzarino M
    Biomed Pharmacother; 2002 May; 56(3):139-43. PubMed ID: 12046685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
    Rajkumar SV
    Hematology Am Soc Hematol Educ Program; 2005; ():340-5. PubMed ID: 16304401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small fiber neuropathy associated with multiple myeloma and IgA monoclonal gammopathy.
    Zivković SA; Delios A; Lacomis D; Lentzsch S
    Ann Hematol; 2009 Oct; 88(10):1043-4. PubMed ID: 19277656
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal gammopathy: The good, the bad and the ugly.
    Glavey SV; Leung N
    Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.
    Gilmore BA; Rodby RA; Cimbaluk D; Venugopal P; Patel P; Barton K; Hagen P; Rodriguez T; Sumoza L; Bishop MR; Dhakal B; Hari P; Paner A
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e251-e258. PubMed ID: 30987953
    [No Abstract]   [Full Text] [Related]  

  • 8. Biclonal gammopathy in multiple myeloma: a case report.
    Bakta IM; Sutarka IN
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy with hyperlipidemia.
    Ozer FL; Telatar H; Telatar F; Müftüoğlu E
    Am J Med; 1970 Dec; 49(6):841-4. PubMed ID: 5006623
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP; Kastritis E; Gkotzamanidou M; Christoulas D; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Roussou M; Margeli A; Papassotiriou I; Dimopoulos MA; Terpos E
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):29-35. PubMed ID: 26632077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.
    Mehtat Ünlü Ş; Özsan H; Sarıoğlu S
    Turk J Haematol; 2017 Dec; 34(4):282-288. PubMed ID: 28832010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple myeloma and renal impairment].
    Takahashi N
    Nihon Rinsho; 2015 Jan; 73(1):38-41. PubMed ID: 25626301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal impairment at presentation in multiple myeloma continues to be associated with poor survival.
    Laing AA; Geddes C; Soutar R
    Br J Haematol; 2015 Jun; 169(6):901-2. PubMed ID: 25522297
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of paraproteinaemia.
    Cook L; Macdonald DH
    Postgrad Med J; 2007 Apr; 83(978):217-23. PubMed ID: 17403946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple myeloma with double gammopathy (IgA-kappa, IgA-lambda) : induction of complete remission from plateau phase with interferon-alpha 2a therapy].
    Kanoh T
    Rinsho Ketsueki; 1996 Apr; 37(4):335-9. PubMed ID: 8847805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lower limb edema and monoclonal gammopathy in a 74-year-old man].
    Bureau C; Moulonguet Doleris L; Bidegain F; Seidowsky A; Trad S; Prinseau J; Hanslik T; Schmied E
    Rev Med Interne; 2013 Oct; 34(10):649-52. PubMed ID: 24075590
    [No Abstract]   [Full Text] [Related]  

  • 17. Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance.
    Silverman S; Vescio R; Silver D; Renner S; Weiner S; Berenson J
    Curr Top Microbiol Immunol; 1996; 210():367-74. PubMed ID: 8565579
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma: most common end-organ damage and management.
    Hussein MA
    J Natl Compr Canc Netw; 2007 Feb; 5(2):170-8. PubMed ID: 17335686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5th International Symposium on clinical applications of serum free light chain analysis].
    Decaux O
    Rev Med Interne; 2009 Jan; 30(1):96-100. PubMed ID: 19054596
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.